4D Molecular Therapeutics News and Activities

Presence

4D Molecular Therapeutics develops gene therapy medicines for eye, lung, and heart diseases. Its main services include research, clinical development, and treatment programs for patients, healthcare providers, and biopharma partners.

4D Molecular Therapeutics products and services overview:

Gene therapies
Eye treatments
Lung treatments
Heart treatments
Clinical development
Research services

Revenue: ~$4 million

Employees: 260

Headquarters: Emeryville, United States (USA)

4D Molecular Therapeutics is one of the...

4D Molecular Therapeutics is a company listed under the stock ticker FDMT (US).

Executives

View the org chart displaying its 33 main executives

Most searched biographies at 4D Molecular Therapeutics

Popular executive movements at 4D Molecular Therapeutics

Glenn Sblendorio has joined the company as Director (posted on January 9 2026).
David Kirn who was Chief Executive Officer and Director, becomes President (posted on January 9 2026).
Fred Kamal, President and Chief Operating Officer, has left the company (posted on January 9 2026).

Click here to view some more movements at 4D Molecular Therapeutics

Create your alert
to follow the executive moves at 4D Molecular Therapeutics.